Gene · 8648
Papers3,138
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,138
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges. | J Enzyme Inhib Med Chem | 2022 | 35702041 | PubTator, text mining | PubMed |
| The evolution and structure/function of bHLH-PAS transcription factor family. | Biochem Soc Trans | 2022 | 35695677 | PubTator, text mining | PubMed |
| Steroid Receptor Coactivator-1 (SRC-1) Promoted Cell Metastasis of Gastric Cancer via VEGFC Activator by NF-κB. | Crit Rev Eukaryot Gene Expr | 2022 | 35695662 | PubTator, text mining | PubMed |
| Action Sites and Clinical Application of HIF-1α Inhibitors. | Molecules | 2022 | 35684364 | PubTator, text mining | PubMed |
| Benzo[a]pyrene-Environmental Occurrence, Human Exposure, and Mechanisms of Toxicity. | Int J Mol Sci | 2022 | 35683027 | PubTator, text mining | PubMed |
| The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes. | Cell Biosci | 2022 | 35659740 | PubTator, text mining | PubMed |
| Human Milk Lipids Induce Important Metabolic and Epigenetic Changes in Neonates. | Clin Perinatol | 2022 | 35659090 | PubTator, text mining | PubMed |
| New Insights on the Regulatory Gene Network Disturbed in Central Areolar Choroidal Dystrophy-Beyond Classical Gene Candidates. | Front Genet | 2022 | 35656327 | PubTator, text mining | PubMed |
| Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study. | Obes Surg | 2022 | 35654930 | PubTator, text mining | PubMed |
| Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors. | Front Genet | 2022 | 35646090 | PubTator, text mining | PubMed |
| Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. | Pharmaceuticals (Basel) | 2022 | 35631448 | PubTator, text mining | PubMed |
| Nuclear Receptor Coregulators in Hormone-Dependent Cancers. | Cancers (Basel) | 2022 | 35626007 | PubTator, text mining | PubMed |
| Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs. | PLoS Genet | 2022 | 35604932 | PubTator, text mining | PubMed |
| Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer. | PLoS One | 2022 | 35594510 | PubTator, text mining | PubMed |
| DVL1 and DVL3 require nuclear localisation to regulate proliferation in human myoblasts. | Sci Rep | 2022 | 35589804 | PubTator, text mining | PubMed |
| Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents. | J Enzyme Inhib Med Chem | 2022 | 35589670 | PubTator, text mining | PubMed |
| Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke. | Front Neurosci | 2022 | 35585925 | PubTator, text mining | PubMed |
| Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor. | J Cutan Pathol | 2022 | 35583270 | PubTator, text mining | PubMed |
| Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. | Elife | 2022 | 35575456 | PubTator, text mining | PubMed |
| Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. | Int J Mol Sci | 2022 | 35563117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8648/papers?page=19